You are here
Forum
-
Patient Day- 2014sandy craine on 20 February 2014
-
Infographic of NICE treatment Pathways for Leukaemiasandy craine on 21 February 2014
-
by sandy craine (Feb 21)
-
-
A Timeline of Vitamin Medicine by Andrew W. Saul, Editor Orthomolecular Medicine News Servicesandy craine on 15 February 2014
-
NICEs' Infographic showing the Treatment Pathways for Leukaemia- including CMLsandy craine on 11 February 2014
-
by sandy craine (Feb 11)
-
-
Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogesandy craine on 11 February 2014
-
vitamin C in cancer patientstartancaddy on 9 February 2014
-
Bone Drug Kills Leukemia in Micesandy craine on 20 January 2014
-
ARIAD Announces the Commercial Availability of Iclusig (Ponatinib) for Patients with Refractory Philadelphia-Positive Leukemiassandy craine on 17 January 2014
-
-
Economist Articlecdw5000 on 4 January 2014
-
Avril's 2015 BUPA London 10K pagesandy craine on 17 February 2015
-
Individual Funding Requests for dasatinib bosutinib ponatinib in Walessandy craine on 23 December 2013
-
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positsandy craine on 21 December 2013
-
Survey: effects of using internet forums on wellbeingsandy craine on 20 December 2013
-
Ariad Pharmaceuticals - Positive News From Regulatorssandy craine on 18 December 2013
-
Greetings and good wishes over the Festive SeasonBasil from RSA on 16 December 2013
-
Patient Day Oxford: Slide presentationssandy craine on 16 December 2013
-
Pfizer withdraws Bosulif in Germanysandy craine on 10 December 2013
-
EHA Survey: Access to Medicinesandy craine on 5 December 2013
-
New FaceBook group for CML patients in TFR (Treatment free Remission)Basil from RSA on 25 November 2013
-
EMA press release: CHMP makes recommendations for use of ARIAD's Iclusig (ponatinib)sandy craine on 22 November 2013